These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31632586)

  • 1. LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p.
    Xin Y; He X; Zhao W; Zhan M; Li Y; Xiao J; He K; Lu L
    Am J Transl Res; 2019; 11(9):6185-6195. PubMed ID: 31632586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA PCAT6 promotes non-small cell lung cancer cell proliferation, migration and invasion through regulating miR-330-5p.
    Cui LH; Xu HR; Yang W; Yu LJ
    Onco Targets Ther; 2018; 11():7715-7724. PubMed ID: 30464520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis.
    Wang W; Li X; Guan C; Hu Z; Zhao Y; Li W; Jiang X
    Pathol Res Pract; 2020 Sep; 216(9):153074. PubMed ID: 32825947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of lncRNA
    Shi R; Wu P; Liu M; Chen B; Cong L
    Onco Targets Ther; 2020; 13():3025-3037. PubMed ID: 32308433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA PCAT6 aggravates the progression of bladder cancer cells by targeting miR-513a-5p.
    Xia W; Chen C; Zhang MR; Zhu LN
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9908-9914. PubMed ID: 33090394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma
    Tu J; Wu F; Chen L; Zheng L; Yang Y; Ying X; Song J; Chen C; Hu X; Zhao Z; Ji J
    Front Oncol; 2020; 10():605877. PubMed ID: 33552977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PCAT6 promotes the occurrence of laryngeal squamous cell carcinoma via modulation of the miR-4731-5p/NOTCH3 axis.
    Bai J; Yao F; Fu Y; Kang N; Wen G
    J Radiat Res; 2024 Jul; 65(4):474-481. PubMed ID: 38950346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR-326/hnRNPA2B1 axis in liver cancer.
    Luo J; Zheng J; Hao W; Zeng H; Zhang Z; Shao G
    Oncol Lett; 2021 Jun; 21(6):471. PubMed ID: 33907581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA PCAT6 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of lung adenocarcinoma cell by targeting miR-545-3p.
    Yang C; Huang H; Li Y; Zhuo T; Zhu L; Luo C; Wu Y; Qin S
    Mol Biol Rep; 2023 Apr; 50(4):3557-3568. PubMed ID: 36787056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PCAT6 promotes tumor progression in osteosarcoma via activation of TGF-β pathway by sponging miR-185-5p.
    Zhu C; Huang L; Xu F; Li P; Li P; Hu F
    Biochem Biophys Res Commun; 2020 Jan; 521(2):463-470. PubMed ID: 31676070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
    Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
    Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
    Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
    Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.
    Zhao W; Zhao J; Guo X; Feng Y; Zhang B; Tian L
    BMC Cancer; 2021 Feb; 21(1):142. PubMed ID: 33557774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7.
    Fan F; Lu J; Yu W; Zhang Y; Xu S; Pang L; Zhu B
    Oncol Lett; 2018 Jan; 15(1):386-392. PubMed ID: 29387225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
    Sun ZP; Tan ZG; Peng C; Yi WM
    J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA UCA1 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells through targeting microRNA-122.
    Li O; Yi W; Yang P; Guo C; Peng C
    Exp Ther Med; 2019 Jul; 18(1):25-32. PubMed ID: 31258634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis.
    Wen LJ; Yin JG; Wang YX; Liu K; Zhao JX
    Parasit Vectors; 2023 Dec; 16(1):465. PubMed ID: 38124152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-coding RNA SNHG12, a New Therapeutic Target, Regulates miR-199a-5p/Klotho to Promote the Growth and Metastasis of Intrahepatic Cholangiocarcinoma Cells.
    Yang HG; Wang TP; Hu SA; Hu CZ; Jiang CH; He Q
    Front Med (Lausanne); 2021; 8():680378. PubMed ID: 34239888
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA-7-5p Inhibits Migration, Invasion and Metastasis of Intrahepatic Cholangiocarcinoma by Inhibiting MyD88.
    Tang Y; Tang Z; Yang J; Liu T; Tang Y
    J Clin Transl Hepatol; 2021 Dec; 9(6):809-817. PubMed ID: 34966644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p.
    Li Z; Jiang X; Huang L; Li J; Ji D; Xu Y; Leng K; Cui Y
    J Cell Mol Med; 2019 Dec; 23(12):8258-8268. PubMed ID: 31565837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.